Tandem Diabetes Care Inc (NASDAQ:TNDM) target upped to $10.00, released a report earlier today by B. Riley
- Updated: October 1, 2016
In a report issued 10/2/2016 B. Riley bumped up the target of Tandem Diabetes Care Inc (NASDAQ:TNDM) to $10.00 indicating a possible upside of 0.31%.
Previously on Thursday September 29, 2016, Zacks Investment Research released a statement on Tandem Diabetes Care Inc (NASDAQ:TNDM) bumped up the target price from $0.00 to $9.00 that suggested an upside of 0.13%.
Yesterday Tandem Diabetes Care Inc (NASDAQ:TNDM) traded 3.93% higher at $7.66. Tandem Diabetes Care Inc’s 50-day moving average is $7.26 and its 200-day average is $7.80. With the last stock price down -1.79% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the date range. Trade Volume was down over the average, with 123,838 shares of TNDM changing hands under the typical 192,245
See Chart Below
Tandem Diabetes Care Inc has a with a 52 week low of $6.04 and a 52 week high of $12.48 Tandem Diabetes Care Inc’s market cap is currently $0.
Also covering Tandem Diabetes Care Inc's price target, a total of 8 analysts have issued a research note on the company. The average stock price target is $15.84 with 5 firms rating the stock a strong buy, two equity analysts rating the company a buy, 3 brokerages rating the stock a hold, zero analysts rating the stock a underperform, and finally 0 brokerages rating the stock a sell.
About Tandem Diabetes Care Inc (NASDAQ:TNDM)
Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.